MCM
OLMA icon

MAI Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

MAI Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75 Buy
+5
New +$111 ﹤0.01% 4805

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

MAI Capital Management's OLMA Position: Q1 2026 in Review

MAI Capital Management opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 5 shares worth $75. The stake represents ﹤0.01% of the portfolio and ranks #4805 among its holdings.

195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • MAI Capital Management held 5 shares of Olema Pharmaceuticals worth $75 as of Q1 2026.
  • Olema Pharmaceuticals was a new MAI Capital Management position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4805 holding.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.